-The Hindu “Environmental impact assessment tends to ignore wider impact on biodiversity” In a move that will bring cheer to wildlife lovers but could dismay industry lobbyists already complaining about the difficulty in obtaining green clearances, the government plans to add biodiversity conservation as a new criterion to grant environmental and forest clearances. “There is no biodiversity clearance till now,” admitted Union Environment Minister Jayanthi Natarajan, speaking ahead of the United Nations summit...

-The Hindu The Supreme Court on Monday issued notice to the Union and Manipur governments on a petition filed by Extrajudicial Execution Victim Families Association Manipur (EEVFAM), seeking a probe into cases of extrajudicial killings in the State. A Bench of Justices Aftab Alam and Ms. Ranjana P. Desai issued the notice and appointed advocate Menaka Guruswamy as the amicus curiae. It directed the matter to be listed for further hearing on...

-The Telegraph The enormity of the real challenge before Manmohan Singh is far higher than that posed by Mamata Banerjee. A “perfect storm” is gathering around the economy, according to a Centre-commissioned report packed with suggestions for a series of tough measures that will affect daily life and test the government’s resolve to wade further into unpalatable waters. The report presented by the Vijay Kelkar panel, which was asked to suggest a road...

-The Times of India India will, for the first time, put a cap on the maximum price at which essential drugs, like some commonly used anti-AIDS and anti-cancer drugs, besides a horde of painkillers, anti-TB drugs, sedatives, lipid lowering agents and steroids, can be sold in the country. In a landmark decision, a group of ministers (GoM) headed by agriculture minister Sharad Pawar on Thursday cleared the proposal to bring all 348...

-The Times of India MUMBAI: Consumers can look forward to a reduction in prices of essential medicines, with the Sharad Pawar-led Group of Ministers (GoM) planning to take a final decision on the pharmaceutical policy soon. The GoM will meet on September 27 to examine options under the market price-based mechanism to cap prices of drugs, which may lead to a reduction ranging from 25% to even 90% in some cases,...